(Press-News.org) NEW YORK – May 21, 2024 – The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.
For nearly two decades, CRF® has led the way in pioneering transcatheter therapies for structural heart disease at TVT®. New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions. A world-class educational experience, New York Valves 2024 will unite interventional cardiologists, cardiac surgeons, clinical cardiologists, cardiac imagers, heart failure experts, and other members of the heart team under one roof. With a renewed emphasis on multidisciplinary collaboration, the conference offers attendees the opportunity to harness the collective expertise of all specialties to develop the most effective and personalized treatment strategies for patients with valvular and structural heart disease.
The late-breaking clinical research that will be presented at New York Valves will unveil the latest advances in transcatheter aortic valve replacement, alongside innovations in mitral and tricuspid devices and techniques. Data from these trials will help guide the selection of patients who will benefit most from these procedures and help define optimal treatment strategies, tools, and techniques for new and emerging treatments.
Wednesday, June 5, 2024
Late-Breaking Clinical Trials and Science: TAVR
11:00 AM — 12:00 PM EDT
A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial
Ole De Backer
Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial
Howard C. Herrmann
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry
Neel Butala
Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials
Rebecca T. Hahn
Thursday, June 6, 2024
Late Breaking Clinical Trials and Science: Mitral and Tricuspid
11:00 AM — 12:00 PM EDT
T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial
Brian K. Whisenant
Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy
Joao L. Cavalcante
Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve
Isaac George
Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry
Andrea Scotti
Friday, June 7, 2024
Late Breaking Clinical Trials and Science: TAVR and Mitral 2
11:00 AM — 12:00 PM EDT
Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk
Steven J. Yakubov
Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients
Anita W. Asgar
Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis
Sebastian Ludwig
Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States
Tsuyoshi Kaneko
In addition to the 12 late-breaking science studies, New York Valves will feature:
20+ live cases showcasing groundbreaking procedures performed by world-renowned operators from 12 prestigious medical institutions
Six featured clinical science presentations
Six distinct tracks designed to unite the multidisciplinary heart team:
Advances in Surgical Approaches and Techniques
Transcatheter Valves Interventions
Hot Topics and Clinical Decision-Making For Clinicians
Basic and Advanced Cardiac Imaging
Innovation and FDA Town Halls
Training and Bioskills of Transcatheter Procedures
100+ moderated abstract presentations
And much more!
HOW TO REGISTER:
Media may apply for press registration by emailing jromero@crf.org.
About CRF®
The Cardiovascular Research Foundation® (CRF®) is a global leader in interventional cardiovascular medicine, driving innovation, spearheading groundbreaking research, and transforming education in the field. Through its relentless pursuit of excellence, CRF® not only accelerates medical breakthroughs but also equips healthcare professionals with the tools and knowledge necessary to enhance survival rates and elevate the quality of life for millions worldwide. CRF’s centers of excellence include the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team. For more information, visit www.crf.org.
###
END
EMBARGOED UNTIL: 2:15 p.m. PT, May 21, 2024
Session: C94 - Asthma Quality Improvement, Health Services Research, and Disparities
Utilization of Single Maintenance and Reliever Therapy (SMART) for Moderate and Severe Asthma
Date and Time: Tuesday, May 21, 2024, 2:15 p.m.
Location: San Diego Convention Center, Room 28A-B (Upper Level)
ATS 2024, San Diego – Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians have not adopted this optimal therapy, according to research published ...
Hemangiosarcoma is a common and aggressive type of cancer in dogs that arises from blood vessel cells and spreads very quickly, throughout the body, frequently affecting the spleen, liver, heart and muscles, among other organs.
“Because this type of cancer comes from blood vessels, it is common for these tumors to suddenly cause massive bleeding into the abdomen or chest,” says Heather Gardner, D.V.M., Ph.D., DACVIM (Oncology), GBS20. “Often when a dog is diagnosed, it is an emergency due to the blood loss associated with tumor rupture. They can have other problems related to hemangiosarcoma, such as lethargy, weakness, and ...
The skin or peel of the Jaboticaba berry (Plinia jaboticaba), a native of the Brazilian Atlantic Rainforest, is usually thrown away because of its astringency (due to an abundance of mouth-puckering tannins), yet it can be a powerful ally in the treatment of obesity and metabolic syndrome, according to an article published in the journal Nutrition Research.
Conducted by researchers at the State University of Campinas (UNICAMP) in São Paulo state (Brazil), the study showed that inflammation and blood sugar levels improved in volunteers with obesity and metabolic syndrome who took 15 g per day of powdered jaboticaba peel as a dietary supplement for five weeks.
“The ...
New Rochelle, NY, May 21, 2024—A new study in the peer-reviewed Journal of Neurotrauma contends that a significant fraction of traumatic intracranial aneurysms (TICAs) is missed on initial contrasted scans of patients suffering a civilian gunshot wound to the head (cGSWH). The study was designed to characterize acute TICAs using admission CT angiography (aCTA). Click here to read the article now.
The study showed that the presence of an intracerebral hematoma was the main predictor of TICA in cGSWH. Larger intracerebral hematomas in patients with cGSWH suggest hidden TICAs.
“When CTA was performed acutely, TICAs were ...
With more than 70 countries hosting national elections, 2024 is the biggest election year in history, according to The Economist.
But how misinformation impacts elections, especially with the rise in content generated by artificial intelligence, continues to be of concern.
A research team examined misinformation narratives on social media in 2023 regarding the Taiwanese presidential election on January 13, 2024. They were especially interested in how narratives targeted relations between Taiwan and the United States.
Misinformation targeted mistrust and skepticism toward the U.S. rather ...
OAKLAND, CA – Officials throughout the state of California have developed plans to start deploying green hydrogen at scale in the coming decade in order to reach California’s 2045 climate neutrality targets. A new analysis, published by scientists at PSE Healthy Energy, finds that while certain applications of green hydrogen may present opportunities to lower greenhouse gas emissions, many challenges remain and misalignments between current proposals could undermine progress toward state climate goals.
“Many state and local agencies are counting on massive build outs of green hydrogen infrastructure in the coming decades to achieve their climate targets,” ...
Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to more weight lost in just a year, a new University of Michigan study finds.
Primary care clinicians commonly struggle to help patients develop an individualized weight-management treatment plan during short clinic visits. Previous U-M research showed that most primary care patients with obesity do not lose at least 5% of their body weight, a goal that’s been shown to reduce obesity-related ...
Whether it’s the wafting aroma of our favorite meal or the dangerous fumes seeping from a toxic chemical, the human sense of smell has evolved into a sophisticated system that processes scents through several intricate stages. The brains of mammals have billions of neurons at their disposal to recognize odors they are exposed to, from pleasant to pungent.
Insects such as fruit flies, on the other hand, have a mere 100,000 neurons to work with. Yet their survival is dependent upon their ability to decipher the meaning of complex odor mixtures around them to locate food, seek potential mates and avoid predators. Scientists have pondered how insects are able to smell, or extract ...
A low-cost, tin-based catalyst can selectively convert carbon dioxide to three widely produced chemicals — ethanol, acetic acid and formic acid.
Lurking within the emissions from many industrial operations is an untapped resource — carbon dioxide (CO2). A contributor of greenhouse gas and global warming, it could instead be captured and converted to value-added chemicals.
In a collaborative project involving the U.S. Department of Energy’s (DOE) Argonne National Laboratory, Northern Illinois University and Valparaiso University, ...
DETROIT —
The International Association for Great Lakes Research today announced its new board of directors and has named Donna Kashian, Ph.D., professor of biological sciences and director of environmental sciences in the College of Liberal Arts and Sciences at Wayne State University, as president. Kashian previously served as vice president of the board.
Founded in 1967, the International Association for Great Lakes Research is a scientific organization made up of researchers studying the Laurentian Great Lakes, other large lakes of the world and their watersheds, as well as those ...
